首页> 美国卫生研究院文献>Diabetes Metabolism Journal >Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

【2h】

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

机译：瑞舒伐他汀单药20 mg瑞舒伐他汀5 mg和依泽替米贝10 mg联合疗法对2型糖尿病患者血脂指标的疗效比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy.

机译：载脂蛋白B / A1（apoB / A1）的比率比常规脂质的水平更能预测未来的心血管疾病。与他汀类单一疗法相比，他汀和依泽替米贝联合疗法显示出更多的心脏保护作用。

著录项

期刊名称 Diabetes Metabolism Journal
作者
You-Cheol Hwang; Ji Eun Jun; In-Kyung Jeong; Kyu Jeung Ahn; Ho Yeon Chung;
展开▼
作者单位

展开▼
年(卷),期 2019(43),5
年度 2019
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Apolipoprotein A-I; Apolipoproteins B; Ezetimibe; Fatty acids; nonesterified; Rosuvastatin calcium; Triglycerides;

机译：载脂蛋白A-I;载脂蛋白B;依泽替米贝;脂肪酸;未酯化;瑞舒伐他汀钙;甘油三酸酯;

相似文献

外文文献
中文文献
专利

1. Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy [J] . VaverkovaH., FarnierM., AvernaM., Cardiovascular therapeutics . 2012,第2期

机译：尽管有先前的他汀类药物单一疗法，但无论有无2型糖尿病的高危患者，依泽替米贝/辛伐他汀10/20 mg与瑞舒伐他汀10 mg的脂质改变功效均未得到充分控制
2. Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study [J] . Jiwoo Lee, You-Cheol Hwang, Woo Je Lee, Diabetes therapy . 2020,第4期

机译：罗斯塔汀/欧扎特米贝疗法及罗苏伐他汀单药治疗2型糖尿病患者脂蛋白的疗效和安全性的比较：多中心随机对照研究
3. Efficacy of combination of Ezetimibe 10?mg and rosuvastatin 2.5?mg versus rosuvastatin 5?mg monotherapy for hypercholesterolemia in patients with type 2 diabetes [J] . Keiichi Torimoto, Yosuke Okada, Hiroko Mori, Lipids in Health Disease . 2013,第3期

机译：依泽替米贝10微克和瑞舒伐他汀2.5微克联合瑞舒伐他汀5微克单一疗法对2型糖尿病患者的高胆固醇血症的疗效
4. Comparison of the effects of rosuvastatin and atorvastatin on plasma lipids and cytokines in hyperlipidemic patients with type 2 Diabetes [C] . Yoshino G., Osonoi T., Saitou M International Congress on Coronary Artery Disease . 2011

机译：枸杞子和阿托伐他汀对2型糖尿病患者血浆脂质和细胞因子的影响的比较
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9) [O] . You-Cheol Hwang 2019

机译：响应：罗苏伐他汀单药20 mg瑞舒伐他汀5 mg和依泽替米贝10 mg联合治疗对2型糖尿病患者血脂参数的疗效比较（Diabetes Metab J 2019; 43：582–9）
7. Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2019;43:582–9) [O] . Tae Seo Sohn 2019

机译：字母：罗苏伐他汀单药治疗20毫克与罗苏伐他汀5毫克的疗效与ezetimibe 10 mg组合治疗对2型糖尿病患者的脂质参数进行比较（糖尿病yab J2019; 43：582-9）

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus

摘要

著录项

相似文献

相关主题

期刊订阅